Decision-making requires
a vast amount of structured information. Although paramount to establishing a
representative description of a particular field, identifying and structuring
information is a tedious task. When generating an information structure, it is
essential to make it as complete as possible in order to analyze and draw
correct conclusions from the field. For your convenience, BioSeeker Group has
identified and structured more than 380 industry related breast cancer R&D
projects, compiled in the first edition of this database. This collection of
data describes the R&D activities in this field as near completely as
possible.
Compiling the information in a database file for
convenient transfer of data to your preferred information system will save
hundreds of working hours for you. Depending on the aim of your analysis, it
will enable you to produce simple as well as advanced information analysis on
the spot. Use the database to produce key tables and automated graphs in no more
than a few minutes!
This is one of the world's most comprehensive and
updated information sources describing the structure of the breast cancer
R&D situation. It includes information about new innovative cancer therapies
such as antisense, monoclonal antibodies, gene therapies, antigen- or
cellular-based vaccines, liposomal hormones and antiangiogenesis drugs.
The information is structured in 9 different
segments:
- Company
- Drug name
- Developmental stage
- Therapy given
- Effect
- Effect 2
- Mecanism
- Mecanism 2
- General comments
It includes information from:
- More than 380 industry related breast cancer
R&D projects
- Information on more that 180 companies active
in breast cancer R&D
- Data from 198 clinical trials
- Information on more than 140 preclinical
projects
This part of the database will help you in:
- Tracking cutting edge companies, therapies and
new technologies
- Producing tables and graphs in an instant,
speeding up the information structure needed for your analysis
- Rapid identification of partners &
competitors
- Laying down a comprehensive framework for
further analysis of the field
- Producing presentations surrounding the
development of breast cancer therapeutics
- Identifying emerging breast cancer products
& key areas of pharmaceutical R&D
Publication date: Sept. 26 2003
Price: $1950 (PDF), $2000 (Hardcopy)
Size: 302 pages
